Update on Waldenström Macroglobulinemia (WM)
Presentation
Topics Covered
We invite you to learn more about:
- Waldenström macroglobulinemia (WM)
- Who needs treatment at presentation
- Treatment options for newly diagnosed and relapsed patients
Speaker
Stephen M. Ansell, MD, PhD
Professor of Medicine
Division of Hematology
Mayo Clinic
Rochester, MN
Program Materials
Program Support
Support for this program provided by The Leukemia & Lymphoma Society in collaboration with The International Waldenstrom’s Macroglobulinemia Foundation (IWMF).
For any questions or comments about this program, please email [email protected].
White
Bruce
Bruce
In the fall of 2002, I had a missed call and a “call me when you’re out of class” text from my Dad. I was a sophomore at the University of Georgia when I heard, “Honey, I have cancer. Waldenstrom’s macroglobulinemia (WM).” So, I took a deep breath and asked, “Okay, so what’s next? Surgery? Radiation? Chemo?” “Nothing, we wait until it gets bad enough for treatment.”